Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/full |
_version_ | 1797858985689219072 |
---|---|
author | Andrea Cavazzoni Arianna Palladini |
author_facet | Andrea Cavazzoni Arianna Palladini |
author_sort | Andrea Cavazzoni |
collection | DOAJ |
first_indexed | 2024-04-09T21:22:14Z |
format | Article |
id | doaj.art-f69b31a7bd3f4d53a415b604584780d5 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-09T21:22:14Z |
publishDate | 2023-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-f69b31a7bd3f4d53a415b604584780d52023-03-28T05:41:52ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11806501180650Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumorsAndrea Cavazzoni0Arianna Palladini1Department of Medicine and Surgery, University of Parma, Parma, ItalyDepartment of Molecular Medicine, University of Pavia, Pavia, Italyhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/fullCDKsolid tumorspre-clinicalcombinationRb |
spellingShingle | Andrea Cavazzoni Arianna Palladini Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors Frontiers in Oncology CDK solid tumors pre-clinical combination Rb |
title | Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors |
title_full | Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors |
title_fullStr | Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors |
title_full_unstemmed | Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors |
title_short | Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors |
title_sort | editorial inhibitors of cdk family new perspective and rationale for drug combination in preclinical models of solid tumors |
topic | CDK solid tumors pre-clinical combination Rb |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1180650/full |
work_keys_str_mv | AT andreacavazzoni editorialinhibitorsofcdkfamilynewperspectiveandrationalefordrugcombinationinpreclinicalmodelsofsolidtumors AT ariannapalladini editorialinhibitorsofcdkfamilynewperspectiveandrationalefordrugcombinationinpreclinicalmodelsofsolidtumors |